Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-8,371
Closed -$319K 314
2024
Q1
$319K Buy
8,371
+69
+0.8% +$2.61K 0.05% 277
2023
Q4
$309K Buy
8,302
+2,117
+34% +$71.1K 0.02% 522
2023
Q3
$210K Sell
6,185
-36,431
-85% -$1.38M 0.02% 592
2023
Q2
$1.68M Buy
42,616
+28,079
+193% +$1.01M 0.09% 213
2023
Q1
$453K Hold
14,537
0.02% 442
2022
Q4
$453K Buy
14,537
+2,964
+26% +$107K 0.02% 442
2022
Q3
$429K Sell
11,573
-7,106
-38% -$266K 0.02% 442
2022
Q2
$543K Buy
+18,679
New +$669K 0.02% 454
2022
Q1
Sell
-7,166
Closed -$361K 888
2021
Q4
$361K Buy
7,166
+2,198
+44% +$123K 0.01% 635
2021
Q3
$278K Buy
4,968
+1,534
+45% +$84.7K 0.01% 690
2021
Q2
$203K Buy
+3,434
New +$193K 0.01% 785

Other funds holding PGNY

FDx Advisors's PGNY Position: Q2 2024 in Review

FDx Advisors sold out of Progyny (PGNY) in Q2 2024, closing a stake of 8,371 shares — an estimated $319K sold.

FDx Advisors first reported a position in PGNY in Q2 2021 and held it in 11 quarters. The position peaked at $1.68M in Q2 2023. 324 funds tracked by Wall St. Rank hold PGNY as of Q2 2024.

  • FDx Advisors reported no remaining Progyny position as of Q2 2024 after selling out during the quarter.
  • FDx Advisors sold 8,371 Progyny shares in Q2 2024, an estimated $319K.
  • FDx Advisors first reported a position in Progyny in Q2 2021 and held it in 11 quarters.
  • FDx Advisors's Progyny position peaked at $1.68M in Q2 2023.
  • 324 funds tracked by Wall St. Rank held Progyny as of Q2 2024.

Based on FDx Advisors's 13F filing for Q2 2024, filed 2 Aug 2024.